罗氏在ARVO 2026会议上提出眼科数据. Roche presents ophthalmology data at ARVO 2026 meeting.

罗氏将在丹佛举行的ARVO 2026会议上展示超过45项研究,强调其眼科组合的进步. Roche will present over 45 studies at the ARVO 2026 meeting in Denver, highlighting advancements in its ophthalmology portfolio. 关键发现包括Vabysmo的数据,显示糖尿病黄斑胀和与年龄相关的黄斑退化患者视网膜解剖改善. Key findings include data on Vabysmo showing improved retinal anatomy for patients with diabetic macular edema and age-related macular degeneration. 此外,ALLUVIUM试验的结果表明一种新药 - 瓦米基巴特 (Vamikibart) 在治疗糖尿病黄斑瘤方面具有潜在作用. Additionally, results from the ALLUVIUM trial suggest potential for a new drug, vamikibart, in treating diabetic macular edema.